Review



massarray sars cov 2 variant panel v3 ruo  (agena bioscience)


Bioz Verified Symbol agena bioscience is a verified supplier
Bioz Manufacturer Symbol agena bioscience manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    agena bioscience massarray sars cov 2 variant panel v3 ruo
    Figure 2. Regression analysis of the Xpert® Xpress <t>SARS-CoV-2,</t> Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV tests, including the equation of the line and R2 values. (a) Xpert®
    Massarray Sars Cov 2 Variant Panel V3 Ruo, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 25 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+massarray+test/MassARRAY+SARS-CoV-2+Variant+Panel+Set/pm36611325-60-43-50
    Average 97 stars, based on 25 article reviews
    massarray sars cov 2 variant panel v3 ruo - by Bioz Stars, 2026-10
    97/100 stars

    Images

    1) Product Images from "Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests."

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests.

    Journal: Diagnostics (Basel, Switzerland)

    doi: 10.3390/diagnostics13010034

    Figure 2. Regression analysis of the Xpert® Xpress SARS-CoV-2, Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV tests, including the equation of the line and R2 values. (a) Xpert®
    Figure Legend Snippet: Figure 2. Regression analysis of the Xpert® Xpress SARS-CoV-2, Xpert® Xpress CoV-2 plus and Xpert® Xpress CoV-2/Flu/RSV tests, including the equation of the line and R2 values. (a) Xpert®

    Techniques Used:

    Related Articles

    Mutagenesis:

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests.
    Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or MassARRAY SARS-CoV-2 Variant Panel v3 (RUO) (MassARRAY; Agena Biosciences, San Diego, CA, USA), or by next generation sequencing performed at the NICD. .. In addition, AccuPlex SARS-CoV-2 variant reference material (LGC SeraCare, Milford, MA, USA) was selected from the AccuPlex SARS-CoV-2 Variants Panel 1 (Wuhan, Alpha, Beta and Gamma) and AccuPlex SARS-CoV-2 Variants Panel 2 (Delta) were used to assess the performance of the test on VOC material.

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests
    Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or MassARRAY SARS-CoV-2 Variant Panel v3 (RUO) (MassARRAY; Agena Biosciences, San Diego, CA, USA), or by next generation sequencing performed at the NICD. .. In addition, AccuPlex SARS-CoV-2 variant reference material (LGC SeraCare, Milford, MA, USA) was selected from the AccuPlex SARS-CoV-2 Variants Panel 1 (Wuhan, Alpha, Beta and Gamma) and AccuPlex SARS-CoV-2 Variants Panel 2 (Delta) were used to assess the performance of the test on VOC material.

    Variant Assay:

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests.
    Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or MassARRAY SARS-CoV-2 Variant Panel v3 (RUO) (MassARRAY; Agena Biosciences, San Diego, CA, USA), or by next generation sequencing performed at the NICD. .. In addition, AccuPlex SARS-CoV-2 variant reference material (LGC SeraCare, Milford, MA, USA) was selected from the AccuPlex SARS-CoV-2 Variants Panel 1 (Wuhan, Alpha, Beta and Gamma) and AccuPlex SARS-CoV-2 Variants Panel 2 (Delta) were used to assess the performance of the test on VOC material.

    Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
    Article Snippet: .. We recovered residual viral RNA from all 391 specimens from −80°C storage to undergo testing on the Agena MassARRAY ® SARS-CoV-2 Variant Panel v3 ( https://www.agenabio.com/products/panel/coronavirus-sars-cov-2-variant-detection-research-162panel/#:~:text=The%20MassARRAY%C2%AE%20SARS%2DCoV ,SARS%2DCoV%2D2%20variants., last accessed 4/25/22). ..

    Article Title: A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
    Article Snippet: .. We recovered residual viral RNA from all 391 specimens from −80°C storage to undergo testing on the Agena MassARRAY SARS-CoV-2 Variant Panel v3 ( https://www.agenabio.com/products/panel/coronavirus-sars-cov-2-variant-detection-research-panel , accessed April 5, 2022). ..

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests
    Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or MassARRAY SARS-CoV-2 Variant Panel v3 (RUO) (MassARRAY; Agena Biosciences, San Diego, CA, USA), or by next generation sequencing performed at the NICD. .. In addition, AccuPlex SARS-CoV-2 variant reference material (LGC SeraCare, Milford, MA, USA) was selected from the AccuPlex SARS-CoV-2 Variants Panel 1 (Wuhan, Alpha, Beta and Gamma) and AccuPlex SARS-CoV-2 Variants Panel 2 (Delta) were used to assess the performance of the test on VOC material.

    Article Title: A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
    Article Snippet: .. Agena MassARRAY® SARS-CoV-2 Variant Panel v3 (RUO) results ID Collection Date GISAID Accession a PANGO Lineage (WGS) Agena Variant Results b Genetic Markers Detected c PV17741 9/2/20 EPI_ISL_802220 B.1.239 D614G Detected. ..

    Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
    Article Snippet: .. We assessed the diagnostic performance of the highly multiplexed Agena MassARRAY ® SARS-CoV-2 Variant Panel v3 to identify variants in a diverse set of 391 SARS-CoV-2 clinical RNA specimens collected across our health systems in New York City, USA as well as in Bogotá, Colombia (September 2, 2020 – March 2, 2022). ..

    Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
    Article Snippet: .. These specimens had previously undergone WGS for epidemiologic surveillance, and we used this data as a benchmark to evaluate the diagnostic performance of the Agena MassARRAY ® SARS-CoV-2 Variant Panel v3 (research use only, RUO). ..

    Next-Generation Sequencing:

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests.
    Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or MassARRAY SARS-CoV-2 Variant Panel v3 (RUO) (MassARRAY; Agena Biosciences, San Diego, CA, USA), or by next generation sequencing performed at the NICD. .. In addition, AccuPlex SARS-CoV-2 variant reference material (LGC SeraCare, Milford, MA, USA) was selected from the AccuPlex SARS-CoV-2 Variants Panel 1 (Wuhan, Alpha, Beta and Gamma) and AccuPlex SARS-CoV-2 Variants Panel 2 (Delta) were used to assess the performance of the test on VOC material.

    Article Title: Rapid Evaluation of the Xpert ® Xpress CoV-2 plus and Xpert ® Xpress CoV-2/Flu/RSV plus Tests
    Article Snippet: .. These specimens were selected by COVID-19 wave and were previously genotyped by the AllPlex SARS-CoV-2 Variants I and II and NovaPlex SARS-CoV-2 Variants V tests (all Seegene, Seoul, Republic of Korea) and/or TaqMan SARS-CoV-2 Mutation Panels (Thermo Fisher Scientific, Waltham, MA, USA) and/or MassARRAY SARS-CoV-2 Variant Panel v3 (RUO) (MassARRAY; Agena Biosciences, San Diego, CA, USA), or by next generation sequencing performed at the NICD. .. In addition, AccuPlex SARS-CoV-2 variant reference material (LGC SeraCare, Milford, MA, USA) was selected from the AccuPlex SARS-CoV-2 Variants Panel 1 (Wuhan, Alpha, Beta and Gamma) and AccuPlex SARS-CoV-2 Variants Panel 2 (Delta) were used to assess the performance of the test on VOC material.

    Whole Complete genome sequencing:

    Article Title: A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 Variants
    Article Snippet: .. Agena MassARRAY® SARS-CoV-2 Variant Panel v3 (RUO) results ID Collection Date GISAID Accession a PANGO Lineage (WGS) Agena Variant Results b Genetic Markers Detected c PV17741 9/2/20 EPI_ISL_802220 B.1.239 D614G Detected. ..

    Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
    Article Snippet: .. These specimens had previously undergone WGS for epidemiologic surveillance, and we used this data as a benchmark to evaluate the diagnostic performance of the Agena MassARRAY ® SARS-CoV-2 Variant Panel v3 (research use only, RUO). ..

    Diagnostic Assay:

    Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
    Article Snippet: .. We assessed the diagnostic performance of the highly multiplexed Agena MassARRAY ® SARS-CoV-2 Variant Panel v3 to identify variants in a diverse set of 391 SARS-CoV-2 clinical RNA specimens collected across our health systems in New York City, USA as well as in Bogotá, Colombia (September 2, 2020 – March 2, 2022). ..

    Article Title: A robust, highly multiplexed mass spectrometry assay to identify SARS-CoV-2 variants
    Article Snippet: .. These specimens had previously undergone WGS for epidemiologic surveillance, and we used this data as a benchmark to evaluate the diagnostic performance of the Agena MassARRAY ® SARS-CoV-2 Variant Panel v3 (research use only, RUO). ..



    Similar Products

    97
    agena bioscience sars cov 2 massarray test
    Schematic representation <t>of</t> <t>(a)</t> <t>SARS-Cov-2</t> virion and its structural protein (b) spike protein denoting S1 and S2 subunit and its binding with ACE2 receptor. [Created with BioRender.com .]
    Sars Cov 2 Massarray Test, supplied by agena bioscience, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+massarray+test/SARS-CoV-2+Panel/pmc11112543-262-7-12
    Average 97 stars, based on 1 article reviews
    sars cov 2 massarray test - by Bioz Stars, 2026-10
    97/100 stars
      Buy from Supplier

    90
    Ethos Laboratories sars-cov-2 massarray test
    Schematic representation <t>of</t> <t>(a)</t> <t>SARS-Cov-2</t> virion and its structural protein (b) spike protein denoting S1 and S2 subunit and its binding with ACE2 receptor. [Created with BioRender.com .]
    Sars Cov 2 Massarray Test, supplied by Ethos Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/sars-cov-2+massarray+test/ethos+sars+cov+2+maldi+tof+assay/pmc11112543-250-0-4
    Average 90 stars, based on 1 article reviews
    sars-cov-2 massarray test - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    Schematic representation of (a) SARS-Cov-2 virion and its structural protein (b) spike protein denoting S1 and S2 subunit and its binding with ACE2 receptor. [Created with BioRender.com .]

    Journal: Analytical Chemistry

    Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease

    doi: 10.1021/acs.analchem.3c05225

    Figure Lengend Snippet: Schematic representation of (a) SARS-Cov-2 virion and its structural protein (b) spike protein denoting S1 and S2 subunit and its binding with ACE2 receptor. [Created with BioRender.com .]

    Article Snippet: Different LoDs have been observed for the SARS-CoV-2 MassArray Test (0.69–2.75 copies/mL), Agena SARS-CoV-2 Panel (2.5 copies/mL), and Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay (1 TCID50/mL), with PPA and NPA values for the three tests ranging from 95% to 100%.

    Techniques: Binding Assay

    Schematic representation of the SARS-CoV-2 genome, which includes a single-stranded RNA having various Open Reading Frames (ORF1a, ORF1b, ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8a, ORF8b, ORF9b), leading to the formation of 16 nonstructural protein (nsps1–nsps16), structural proteins like S (spike protein) having the S1 subunit, which includes NTD, RBD, SD1, and SD2 and the S2 subunit, which contains FL, HR1, HR2, and TM. Other structural proteins are E (Envelop protein), M (Membrane protein), N (Nucleocapsid protein). PL-pro (papain-like protease), and 3CL-pro (cysteine proteases). [Created with BioRender.com .]

    Journal: Analytical Chemistry

    Article Title: Evolution and Impact of Nucleic Acid Amplification Test (NAAT) for Diagnosis of Coronavirus Disease

    doi: 10.1021/acs.analchem.3c05225

    Figure Lengend Snippet: Schematic representation of the SARS-CoV-2 genome, which includes a single-stranded RNA having various Open Reading Frames (ORF1a, ORF1b, ORF3a, ORF3b, ORF6, ORF7a, ORF7b, ORF8a, ORF8b, ORF9b), leading to the formation of 16 nonstructural protein (nsps1–nsps16), structural proteins like S (spike protein) having the S1 subunit, which includes NTD, RBD, SD1, and SD2 and the S2 subunit, which contains FL, HR1, HR2, and TM. Other structural proteins are E (Envelop protein), M (Membrane protein), N (Nucleocapsid protein). PL-pro (papain-like protease), and 3CL-pro (cysteine proteases). [Created with BioRender.com .]

    Article Snippet: Different LoDs have been observed for the SARS-CoV-2 MassArray Test (0.69–2.75 copies/mL), Agena SARS-CoV-2 Panel (2.5 copies/mL), and Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay (1 TCID50/mL), with PPA and NPA values for the three tests ranging from 95% to 100%.

    Techniques: Membrane